Wells Fargo & Company Maravai Lifesciences Holdings, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 52,685 shares of MRVI stock, worth $221,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,685

Previous 37,684 39.81%

Holding current value

$221,277

Previous $313,000 8.31%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$4.42 - $8.5 $66,304 - $127,508	15,001 Added 39.81%	52,685 $287,000
Q3 2024 Nov 13, 2024	SELL	$6.84 - $9.73 $12,216 - $17,377	-1,786 Reduced 4.52%	37,684 $313,000
Q2 2024 Aug 13, 2024	BUY	$6.87 - $11.34 $214,179 - $353,535	31,176 Added 375.89%	39,470 $282,000
Q1 2024 May 10, 2024	SELL	$5.11 - $8.76 $6,177 - $10,590	-1,209 Reduced 12.72%	8,294 $71,000
Q4 2023 Feb 09, 2024	SELL	$4.7 - $9.87 $96,514 - $202,680	-20,535 Reduced 68.36%	9,503 $62,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $12.85 $2,010 - $2,827	-220 Reduced 0.73%	30,038 $300,000
Q2 2023 Aug 15, 2023	SELL	$12.09 - $15.0 $27,903 - $34,620	-2,308 Reduced 7.09%	30,258 $376,000
Q1 2023 May 12, 2023	BUY	$12.99 - $16.48 $2,442 - $3,098	188 Added 0.58%	32,566 $456,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $49,062 - $97,261	3,925 Added 13.79%	32,378 $463,000
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $4,799 - $7,076	233 Added 0.83%	28,453 $727,000
Q2 2022 Aug 12, 2022	SELL	$26.05 - $37.48 $889,086 - $1.28 Million	-34,130 Reduced 54.74%	28,220 $801,000
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $1.07 Million - $1.8 Million	-43,900 Reduced 41.32%	62,350 $2.2 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $7.72 Million - $10.1 Million	-220,542 Reduced 67.49%	106,250 $4.45 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $8.64 Million - $14.2 Million	234,785 Added 255.18%	326,792 $16 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $171,810 - $238,185	-5,293 Reduced 5.44%	92,007 $3.84 Million
Q1 2021 May 13, 2021	BUY	$25.8 - $38.49 $781,198 - $1.17 Million	30,279 Added 45.18%	97,300 $3.47 Million
Q4 2020 Feb 09, 2021	BUY	$24.5 - $30.86 $1.64 Million - $2.07 Million	67,021 New	67,021 $1.88 Million

Others Institutions Holding MRVI

# of Institutions

201

Shares Held

139M

Call Options Held

250K

Put Options Held

22.8K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $552M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Maravai Lifesciences Holdings, Inc. Transaction History